IR
Superintel
Overview
Markets
Watchlist
More
Orexigen Therapeutics Inc
Q2 2014 vs Q3 2014
Comparing institutional holders between quarters
Quarters
Q3 2014
Q2 2014
Q1 2014
Q4 2013
Compare
Detailed
Historical
Funds
Options
13D/13G
Peers
Targeting
Trading Summary
Profile
1
Filed
0
New
0
Closed
0
Increased
0
Decreased
1
Unchanged
0
No Data
Sort by
Q3 2014 shares — high to low
Q3 2014 shares — low to high
Share change — largest gain
Share change — largest cut
% change — largest gain
% change — largest cut
Q3 2014 value — high to low
Value change — largest gain
Value change — largest cut
Institution — A to Z
Filed — newest first
Advent Capital Management
UNCHANGED
Shares
20,622,000
from 20,622,000
Change
0
(0%)
Value
$18.8K
(-$526)
Filed 2014-11-14
Institution
Status
Q3 2014 ↓
Q2 2014
Change
% Change
Q2 2014 Value
Q3 2014 Value
Value Change
Filed
Advent Capital Management
UNCHANGED
20,622,000
20,622,000
0
0%
$19.3K
$18.8K
-$526
2014-11-14
Showing 1 of 1 institutions